Robert Hofmeister

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Melinda Lackey, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert Hofmeister

Form 4 holding Chief Scientific Officer

TCR2 THERAPEUTICS INC.

Security class
Common Stock
Shares / value
45,850
Estimated value
$78,862
Report date
09 Dec 2021
Price
$1.72
Ownership
Direct
Form 4 holding Chief Scientific Officer

TCR2 THERAPEUTICS INC.

Security class
Stock Option (Right to Buy)
Shares / value
100,000
Estimated value
$74,000
Report date
09 Dec 2021
Price
$0.7400
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Alaunos Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
12,800
Estimated value
Report date
06 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robert Hofmeister

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .